Dexamethasone augmentation in treatment-resistant depression.

Dinan, T G; Lavelle, E; Cooney, J; Burnett, F; Scott, L; Dash, A; Thakore, J; Berti, C

Dinan, T G; Lavelle, E; Cooney, J; Burnett, F; Scott, L; Dash, A; Thakore, J; Berti, C.

Affiliation

Dinan TG; Department of Psychological Medicine, St Bartholomew's Hospital, London, UK.

Acta Psychiatr Scand ; 95(1): 58-61, 1997 Jan.

Article in En | MEDLINE | ID: mdl-9051162

Subject(s)

Antidepressive Agents, Second-Generation/administration & dosage; Depressive Disorder/drug therapy; Dexamethasone/administration & dosage; Selective Serotonin Reuptake Inhibitors/administration & dosage; 1-Naphthylamine/administration & dosage; 1-Naphthylamine/analogs & derivatives; Adult; Depressive Disorder/psychology; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine/administration & dosage; Humans; Hydrocortisone/blood; Hypothalamo-Hypophyseal System/drug effects; Male; Middle Aged; Personality Inventory; Pituitary-Adrenal System/drug effects; Sertraline; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dexamethasone / Selective Serotonin Reuptake Inhibitors / Antidepressive Agents, Second-Generation / Depressive Disorder Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Psychiatr Scand Year: 1997 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links